Saratov JOURNAL of Medical and Scientific Research

Features of psychoemotional disorders in patients with multiple sclerosis in different clinical and demographic groups

Year: 2018, volume 14 Issue: №1 Pages: 151-153
Heading: Neurology Article type: Short message
Authors: Lukina E.V., Chernysheva О.А., Eliseeva V.A.
Organization: Saratov State Medical University

Purpose: to conduct an analysis of psychoemotional disorders in patients with multiple sclerosis, who are not receiving any treatment for these disorders. Material and Methods. A cohort of patients with a reliable diagnosis of multiple sclerosis, according to the criteria of С Poseur, consisting of 163 people, was selected for the research. A four-dimensional symptomatic questionnaire was used to assess distress, depression, anxiety and somatization (4DSQ) and a self-questionnaire for evaluating the symptoms of fibromyalgia with quantitative measures (WPI, SS, FS). Re-sults. Differences in the average values of the level of distress, depression, anxiety and somatization in patients with multiple sclerosis of different sex, age, with different type of course and duration of the disease are shown. Conclusion. The neuropsychological status of patients depends on the type of course of the disease, the level of distress — from age and sex, the level of somatization —from the age of this category of patients. In the complex treatment of this category of patients it is necessary to use symptomatic treatment in addition to pathogenetic therapy, which has not only neurotrophic and vasoactive effects, but also affects the psychoemotional background of patients.

1 Shmidt ТЕ, Yakhno NN. Multiple sclerosis. Moscow: MEDpress-inform, 2016; 272 p.
2 Caine ED, Schwid SR. Multiplesclerosis, depression, and the risk of suicide. Neurology 2002; 59: 662-3
3 Kneebone II, Dunmore EC, Evans E. Symptoms of depression in older adults with multiple sclerosis (MS): comparison with a matched sample of younger adults. Aging Ment Health 2003; 7 (3): 182-5
4 Lukina EV, Kuznetsova DE. An assessment of the level of anxiety and depression in patients with multiple sclerosis. Saratov Journal of Medical Scientific Research 2012; 8 (2): 484-8
5 Terluin В, van Marwijk HW, Ader HJ, et al. The four-dimensional symptom questionnaire (4DSQ): a validation study of a multidimensional self-report questionnaire to assess distress, depression, anxiety and somatization. ВМС Psychiatry 2006; 6: 34
6 Terluin B, Smits N, Brouwers EP, de Vet HC. The four-dimensional symptom questionnaire (4DSQ) in the general population: scale structure, reliability, measurement invariance and normative data: a cross-sectional survey. Health Qual Life Outcomes 2016; 14(1): 130
7 Jongen PJ, Ruimschotel RP, Museler-Kreijns YM, et al. Improved health-related quality of life, participation, and autonomy in patients with treatment-resistant chronic pain after an intensive social cognitive intervention with the participation of support partners. J Pain Res 2017; 10: 2725-38
8 Stolyarov ID, Osetrov BA (eds.). Multiple sclerosis. St.Petersburg: ELBI-SPb, 2002; 176 p.
9 Bras М, Gregurek R, Milunovic V, et al. Relationship between combat related posttraumatic stress disorder (PTSD) and multiple sclerosis (MS). Psychiatr Danub 2008; 20 (1): 80-4
10 Hart DL, Memoli Rl, Mason B, et al. Developing a Wellness Program for People with Multiple Sclerosis: Description and Initial Results. Int J MS Care 2011; 13 (4): 154-62
11 Vleugels L, Pfennings L, Pouwer F, et al. Psychological functioning in primary progressive versus secondary progressive multiple sclerosis. Br J Med Psychol 1998; 71 (1): 99-106.

2018_01-1_151-153.pdf243.45 KB

No votes yet